Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is sought to investigate any predictors including biomarkers for atrial high rate episodes (AHRE) occurrence in patients without prior history of atrial tachyarrhythmias receiving cardiac implantable electronic device (CIED).
Atrial high rate episodes (AHRE) are noticed up to 70% in patients receiving cardiac implantable electronic device (CIED) even in the absence of prior history of atrial tachyarrhythmias. AHRE is clinically important because it is considered to be associated with clinical atrial fibrillation, stroke, mortality, and heart failure hospitalization. Therefore, predictors of AHRE might be useful for early detection of AHRE susceptable CIED recipients. Biomarkers as well as clinical characteristics will be analyzed.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients receiving cardiac implantable electronic device | Patients receiving cardiac implantable electronic device for any clinical indication |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| implantable cardiac electronic device recipients | Device | implantable cardiac electronic device recipients for any clinical indication |
|
| Measure | Description | Time Frame |
|---|---|---|
| The occurrence of atrial high rate episode | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Factors predicting the occurrence of atrial high rate episode | factors including biomarkers such as FGF-23 and soluble ST-2, and single nucleotide polymorphism | 12 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients receiving cardiac implantable electronic device for any clinical indication (pacemaker, implantable cardioverter-defibrillator, cardiac resynchronization therapy)
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jinhee Ahn, MD | Contact | 82-10-4840-5563 | reinee7@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Jinhee Ahn, MD | Clinical associate professor | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Jinhee Ahn | Busan | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D017147 | Defibrillators, Implantable |
| D058406 | Cardiac Resynchronization Therapy |
| ID | Term |
|---|---|
| D047548 | Defibrillators |
| D004566 | Electrodes |
| D055615 | Electrical Equipment and Supplies |
| D004864 | Equipment and Supplies |
Not provided
Not provided
Not provided
Not provided
Not provided
biomarkers including soluble ST-2 and FGF-23, single nucleotide polymorphism
|
| D004567 |
| Electrodes, Implanted |
| D019736 | Prostheses and Implants |
| D002304 | Cardiac Pacing, Artificial |
| D004599 | Electric Stimulation Therapy |
| D013812 | Therapeutics |